Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer
Cited by 71
Related Papers
Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC
|Hepatology|2024|60
Stimulation of Somatic Cell Reprogramming by ERas-Akt-FoxO1 Signaling Axis
|Stem Cells|2013|51
Decitabine inhibits T cell proliferation via a novel TET2-dependent mechanism and exerts potent protective effect in mouse auto- and allo-immunity models
|Oncotarget|2017|34
Role of S100A3 in human hepatocellular carcinoma and the anticancer effect of sodium cantharidinate
|Experimental and Therapeutic Medicine|2017|29